
|Videos|November 21, 2017
Dr. Soyer Discusses the Role of Technology in Melanoma
Author(s)Peter Soyer, MD
Peter Soyer, MD, academic dermatologist, professor, The University of Queensland Diamantina Institute, discusses the role of technology in melanoma.
Advertisement
Peter Soyer, MD, academic dermatologist, professor, The University of Queensland Diamantina Institute, discusses the role of technology in melanoma.
In high-risk and ultra high-risk patients, a special surveillance program must be developed, says Soyer. It is not enough to be seen by a physician once a year.
Soyer says that “innovative surveillance” utilizes technology like artificial intelligence and smart phones, possibly aiding in the diagnosis of skin cancer and melanoma.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5




































